Chargement en cours...
Treating cancer when pRb and p53 cannot be reactivated
Activation of oncoproteins and inactivation of tumor suppressors induces tumorigenesis. When these events happen upstream of pRb and p53, cancer therapies may initially succeed and then fail when pRb and p53 are activated and then re-inactivated. Therapies might succeed if they remain effective when...
Enregistré dans:
| Publié dans: | Mol Cell Oncol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905341/ https://ncbi.nlm.nih.gov/pubmed/27308498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1004954 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|